Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
Due to the lack of randomized controlled trials, the best follow-up strategy of asymptomatic patients after coronary artery revascularization is controversial. A systematic screening of silent myocardial ischemia may help prevent a major acute cardiac event. However, systematic screening strategy is costly and there is currently no evidence that repeated revascularization improve survival. Moreover, stress testing per se or additional procedures which can be performed with regard of stress testing results can cause unexpected complications. ARCACHON is a national, multicenter, randomized, open label trial, that will evaluate the non-inferiority of a clinical follow-up as compared to a systematic stress testing strategy after coronary revascularization.
Official title: Assessment in a Randomized Controlled Trial of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
2664
Start Date
2021-09-30
Completion Date
2025-09-30
Last Updated
2024-06-03
Healthy Volunteers
No
Interventions
No stress testing
No stress testing during the patient follow up (up to 48 months) if the patient remains asymptomatic
stress testing
Systematic annual stress testing during the patient follow up (up to 48 months)
Locations (1)
Pitie salpetriere
Paris, France